Healthcare

Drug Delivery Devices Market Size to Reach over USD 365 Billion by 2030

Share This Article

Drug Delivery Devices Market size was valued at USD 225 billion in 2021 and is expected to reach over USD 365 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 7.5% during the forecast period 2021 to 2030.

Get the sample pages of report@ https://www.precedenceresearch.com/sample/1395

What are the growth factors?

The global drug delivery devices market is primarily driven by the rising prevalence of various chronic diseases such as cancer, diabetes, and cardiovascular diseases among the global population. The rapid growth of the biopharmaceuticals industry resulted in the development of various innovative drugs that can effectively treat various chronic diseases.The rising number of diabetic population is fostering the growth of this segment as the diabetic patient need to regularly inject insulin.

The technological advancements are providing easy to use and convenient administration of drugs through various roots, which is expected to drive the drug and gene delivery devices market across the globe.

Report Highlights

  • North America dominated the global drug delivery devices market in 2020. The increased number of patients suffering from chronic diseases in the US has fostered the market growth in the region.
  • Based on the route of administration, the topical segment is estimated to be the most opportunistic market during the forecast period. The topical segment offers non-invasiveness, ease of use, convenience, and painless delivery, which is expected to be the major driver of this segment. The introduction of the time-controlled drug administration feature is further fueling the demand for the topical segment.
  • Based on the application, the cancer segment dominated the market owing to the increased prevalence of cancer among the population. According to the International Agency for Research on Cancer, in 2020, around 19.3 million new cancer cases and 10 million cancer deaths were reported across the globe. The global cancer cases are estimated to grow by 47% from 2020 to 2040. It is expected that 28.4 million cases will be recorded in 2040, globally.
  • Based on the end user, the home healthcare segment is expected to be the fastest-growing segment owing to the increasing geriatric population, increased disposable income, rising demand for getting the treatment at home, and increased awareness regarding the hospital acquired infections.
  • Asia Pacific is estimated to be the fastest-growing market during the forecast period. The presence of several top biopharmaceutical companies in the nations like India, China, and South Korea is propelling the market growth.

Ask here for customization@ https://www.precedenceresearch.com/customization/1395

Recent report on the Drug Delivery Devices market, with the help of a comprehensive outlook, provides readers with an assessment of the global market landscape. This study on the Drug Delivery Devices market analyzes the scenario for the period of 2017 to 2030, wherein, 2021 is the base year and 2020 is historical data. This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global Drug Delivery Devices market for the forecast period of 2021–2030. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global Drug Delivery Devices market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the Drug Delivery Devices market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the market.

The report delves into the competition landscape of the global Drug Delivery Devices market. Key players operating in the market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the Drug Delivery Devices market that are profiled in this report.

Y-o-Y growth comparison, volume and revenue comparison, and market share comparison of various market segments are provided in the report. The Drug Delivery Devices market is analyzed at both regional and country levels.

Key Players

  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd
  • Johnson and Johnson Private Ltd
  • Novartis AG
  • Bayer AG
  • Becton, Dickinson and Company
  • Uniqure NV

Key Questions are

  • What are the key factors influencing the Drug Delivery Devices market in each region?
  • How much value will the global market generate by the end of the forecast period?
  • What will be the CAGR of the global market between 2019 and 2030?
  • What would be the Y-o-Y growth trend of the global market between 2019 and 2030?
  • What is the future scope and current trends in technologies of the global market?
  • What is the revenue of the global market based on segments?
  • Which key strategies are used by top players of the global market?
  • Which are the leading companies in the global market?
  • What are the essential strategies by key stakeholders in the market to expand their geographic presence?
  • What are the major advancements witnessed in the global market?

Ask here for customization study@

Research Methodology

A unique research methodology has been utilized to conduct a comprehensive research on the growth of the global Drug Delivery Devices market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global Drug Delivery Devices market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.

Market Segmentation

By Route of Administration

  • Oral
  • Ocular
  • Inhalation
  • Nasal
  • Injectable
  • Topical
  • Others

By Application

  • Cardiovascular
  • Diabetes
  • Cancer
  • Infectious Diseases
  • Others

By End User

  • Hospitals
  • Ambulatory Services
  • Home Healthcare

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Buy this Research Report study@ https://www.precedenceresearch.com/checkout/1395

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333

Show More

Steve Robber

My name is Steve Robber, I’m the Owner of Market Stats News. Steve has served in many positions at various organizations for the past seven years. Currently he is an Author at Finance.Yahoo. Contact us for a free news publication, we look forward to speaking with you!

Related Articles

Back to top button